Mechanism mediated by a noncoding RNA, nc886, in the cytotoxicity of a DNA-reactive compound

Published on Apr 23, 2019in Proceedings of the National Academy of Sciences of the United States of America9.412
· DOI :10.1073/PNAS.1814510116
Nawapol Kunkeaw7
Estimated H-index: 7
(MU: Mahidol University),
Yeon-Su Lee24
Estimated H-index: 24
+ 16 AuthorsYong Sun Lee19
Estimated H-index: 19
Sources
Abstract
DNA-reactive compounds are harnessed for cancer chemotherapy. Their genotoxic effects are considered to be the main mechanism for the cytotoxicity to date. Because this mechanism preferentially affects actively proliferating cells, it is postulated that the cytotoxicity is specific to cancer cells. Nonetheless, they do harm normal quiescent cells, suggesting that there are other cytotoxic mechanisms to be uncovered. By employing doxorubicin as a representative DNA-reactive compound, we have discovered a cytotoxic mechanism that involves a cellular noncoding RNA (ncRNA) nc886 and protein kinase R (PKR) that is a proapoptotic protein. nc886 is transcribed by RNA polymerase III (Pol III), binds to PKR, and prevents it from aberrant activation in most normal cells. We have shown here that doxorubicin evicts Pol III from DNA and, thereby, shuts down nc886 transcription. Consequently, the instantaneous depletion of nc886 provokes PKR and leads to apoptosis. In a short-pulse treatment of doxorubicin, these events are the main cause of cytotoxicity preceding the DNA damage response in a 3D culture system as well as the monolayer cultures. By identifying nc886 as a molecular signal for PKR to sense doxorubicin, we have provided an explanation for the conundrum why DNA-damaging drugs can be cytotoxic to quiescent cells that have the competent nc886/PKR pathway.
Figures & Tables
Download
📖 Papers frequently viewed together
20 Citations
27 Citations
20127.08eLife
3 Authors (Bray Denard, ..., Jin Ye)
95 Citations
References41
Newest
#1Ji Hye Ahn (Kyung Hee University)H-Index: 1
#2Hyun-Sung Lee (BCM: Baylor College of Medicine)H-Index: 25
Last. Yong Sun Lee (UTMB: University of Texas Medical Branch)H-Index: 19
view all 16 authors...
Transforming growth factor-β (TGF-β) signaling and microRNAs (miRNAs) are important gene regulatory components in cancer. Usually in advanced malignant stages, TGF-β signaling is elevated but global miRNA expression is suppressed. Such a gene expression signature is well illustrated in a fibrosis (or mesenchymal) subtype of ovarian cancer (OC) that is of poor prognosis. However, the interplay between the two pathways in the OC subtype has not yet been elucidated. nc886 is a recently identified n...
24 CitationsSource
#1J-L ParkH-Index: 1
#2Y-S LeeH-Index: 4
Last. Yong Sun Lee (UTMB: University of Texas Medical Branch)H-Index: 19
view all 13 authors...
RNA polymerase III (Pol III) transcribes medium-sized non-coding RNAs (collectively termed Pol III genes). Emerging diverse roles of Pol III genes suggest that individual Pol III genes are exquisitely regulated by transcription and epigenetic factors. Here we report global Pol III expression/methylation profiles and molecular mechanisms of Pol III regulation that have not been as extensively studied, using nc886 as a representative Pol III gene. In a human mammary epithelial cell system that rec...
17 CitationsSource
The protein kinase R (PKR, also called EIF2AK2) is an interferon-inducible double-stranded RNA protein kinase with multiple effects on cells that plays an active part in the cellular response to numerous types of stress. PKR has been extensively studied and documented for its relevance as an antiviral agent and a cell growth regulator. Recently, the role of PKR related to metabolism, inflammatory processes, cancer and neurodegenerative diseases has gained interest. In this review, we summarise a...
13 CitationsSource
#1Hee Jin Jang (SNU: Seoul National University)H-Index: 16
#2Hyun-Sung LeeH-Index: 25
Last. Ju Seog Lee (University of Texas MD Anderson Cancer Center)H-Index: 62
view all 26 authors...
Objective Oesophageal squamous cell carcinoma (ESCC) is a heterogeneous disease with variable outcomes that are challenging to predict. A better understanding of the biology of ESCC recurrence is needed to improve patient care. Our goal was to identify small non-coding RNAs (sncRNAs) that could predict the likelihood of recurrence after surgical resection and to uncover potential molecular mechanisms that dictate clinical heterogeneity. Design We developed a robust prediction model for recurrenc...
22 CitationsSource
#1Jong Lyul Park (Korea Research Institute of Bioscience and Biotechnology)H-Index: 11
Last. Yong Sun LeeH-Index: 19
view all 5 authors...
RNA polymerase III (Pol III) synthesizes a range of medium-sized noncoding RNAs (collectively ‘Pol III genes’) whose early established biological roles were so essential that they were considered ‘housekeeping genes’. Besides these fundamental functions, diverse unconventional roles of mammalian Pol III genes have recently been recognized and their expression must be exquisitely controlled. In this review, we summarize the epigenetic regulation of Pol III genes by chromatin structure, histone mo...
17 CitationsSource
#1Eun Kyung LeeH-Index: 18
#2Seung-Hyun HongH-Index: 23
Last. Yong Sun Lee (UTMB: University of Texas Medical Branch)H-Index: 19
view all 15 authors...
// Eun Kyung Lee 1, * , Seung-Hyun Hong 2, * , Sooyong Shin 3, 4, * , Hyun-Sung Lee 5 , Ju-Seog Lee 6 , Eun Jung Park 7, 8 , Sun Shim Choi 9 , Jae Woong Min 9 , Daeyoon Park 1 , Jung-Ah Hwang 2 , Betty H. Johnson 3 , Sung Ho Jeon 4 , In-Hoo Kim 8 , Yeon-Su Lee 2 , Yong Sun Lee 3, 8 1 Center for Thyroid Cancer, National Cancer Center, Goyang, 410-769, Korea 2 Cancer Genomics Branch, Research Institute, National Cancer Center, Goyang, 410-769, Korea 3 Department of Biochemistry and Molecular Biolo...
20 CitationsSource
#1Francesco Iorio (EMBL-EBI: European Bioinformatics Institute)H-Index: 29
#2Theo A. Knijnenburg (NKI-AVL: Netherlands Cancer Institute)H-Index: 26
Last. Mathew J. Garnett (Wellcome Trust Sanger Institute)H-Index: 40
view all 39 authors...
Systematic studies of cancer genomes have provided unprecedented insights into the molecular nature of cancer. Using this information to guide the development and application of therapies in the clinic is challenging. Here, we report how cancer-driven alterations identified in 11,289 tumors from 29 tissues (integrating somatic mutations, copy number alterations, DNA methylation, and gene expression) can be mapped onto 1,001 molecularly annotated human cancer cell lines and correlated with sensit...
889 CitationsSource
#1Yong Sun Lee (UTMB: University of Texas Medical Branch)H-Index: 1
#1Yong Sun Lee (UTMB: University of Texas Medical Branch)H-Index: 19
nc886 (=vtRNA2-1, pre-miR-886, or CBL3) is a newly identified non-coding RNA (ncRNA) that represses the activity of protein kinase R (PKR). nc886 is transcribed by RNA polymerase III (Pol III) and is intriguingly the first case of a Pol III gene whose expression is silenced by CpG DNA hypermethylation in several types of cancer. PKR is a sensor protein that recognizes evading viruses and induces apoptosis to eliminate infected cells. Like viral infection, nc886 silencing activates PKR and induce...
29 CitationsSource
#1Osama A. Youssef (UofU: University of Utah)H-Index: 6
#2Sarah A. Safran (UofU: University of Utah)H-Index: 2
Last. Brenda L. Bass (UofU: University of Utah)H-Index: 50
view all 6 authors...
Protein kinase RNA-activated (PKR) has long been known to be activated by viral double-stranded RNA (dsRNA) as part of the mammalian immune response. However, in mice PKR is also activated by metabolic stress in the absence of viral infection, and this requires a functional kinase domain, as well as a functional dsRNA-binding domain. The endogenous cellular RNA that potentially leads to PKR activation during metabolic stress is unknown. We investigated this question using mouse embryonic fibrobl...
72 CitationsSource
#1Maddaly Ravi (SRU: Sri Ramachandra University)H-Index: 6
#2V. ParameshH-Index: 2
Last. F.D. Paul SolomonH-Index: 1
view all 5 authors...
Cell cultures are important material of study for the variety of advantages that they offer. Both established continuous cell lines and primary cell cultures continue to be invaluable for basic research and for direct applications. Technological advancements are necessary to address emerging complex challenges and the way cells are cultured in vitro is an area of intense activity. One important advancement in cell culture techniques has been the introduction of three dimensional culture systems....
425 CitationsSource
Cited By7
Newest
#1Rafael Sebastián Fort (University of the Republic)H-Index: 6
#2María Ana Duhagon (University of the Republic)H-Index: 12
Background: The vault RNAs (vtRNAs) are a class of 84-141-nt eukaryotic non-coding RNAs transcribed by RNA polymerase III, associated to the ribonucleoprotein complex known as vault particle. Of the four human vtRNA genes, vtRNA1-1, vtRNA1-2 and vtRNA1-3, clustered at locus 1, are integral components of the vault particle, while vtRNA2-1 is a more divergent homologue located in a second locus. Gene expression studies of vtRNAs in large cohorts have been hindered by their unsuccessful sequencing ...
Source
#1Yeon-Su LeeH-Index: 24
#2Xiaoyong Bao (UTMB: University of Texas Medical Branch)H-Index: 1
Last. Yong Sun LeeH-Index: 3
view all 18 authors...
Interferons (IFNs) are a crucial component in the innate immune response. Especially the IFN-β signaling operates in most cell types and plays a key role in the first line of defense upon pathogen intrusion. The induction of IFN-β should be tightly controlled, because its hyperactivation can lead to tissue damage or autoimmune diseases. Activation of the IFN-β promoter needs Interferon Regulatory Factor 3 (IRF3), together with Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB...
Source
The proper functioning of the immune system requires a robust control over a delicate equilibrium between an ineffective response and immune overactivation. Poor responses to viral insults may lead to chronic or overwhelming infection, whereas unrestrained activation can cause autoimmune diseases and cancer. Control over the magnitude and duration of the antiviral immune response is exerted by a finely tuned positive or negative regulation at the DNA, RNA, and protein level of members of the typ...
8 CitationsSource
#1Wenjing Wang (SPU: Shenyang Pharmaceutical University)H-Index: 2
#2Mengyue Zhao (SPU: Shenyang Pharmaceutical University)H-Index: 2
Last. Lihui Wang (SPU: Shenyang Pharmaceutical University)H-Index: 27
view all 14 authors...
Cisplatin is a first-line drug for the treatment of human non-small cell lung cancer (NSCLC); however, the majority of patients will develop drug resistance after treatment. In order to overcome cisplatin resistance, it is important to understand the mechanisms underlying the resistance. A gene microarray was used to screen for genes related to cisplatin resistance in NSCLC cell lines. Subsequently, the correlation between the HDAC, RXR and HtrA1 genes, in NSCLC, were verified using gene manipul...
5 CitationsSource
#1Sujin Kim (KAIST)H-Index: 2
#2Keonyong Lee (KAIST)
Last. Yoosik Kim (KAIST)H-Index: 18
view all 6 authors...
Protein kinase R (PKR) is an immune response protein that becomes activated by long double-stranded RNAs (dsRNAs). Several studies reported the misactivation of PKR in patients of degenerative diseases including primary osteoarthritis (OA). However, the molecular identity of PKR-activating dsRNAs remains unknown. Here, we investigate the role of mitochondrial dsRNAs (mt-dsRNAs) in the development of OA. We find that in response to OA-mimicking stressors, cytosolic efflux of mt-dsRNAs is increase...
Source
#1Ming-Chin Yu (CGU: Chang Gung University)H-Index: 24
#2Chao-Wei Lee (CGU: Chang Gung University)H-Index: 9
Last. Chi-Neu Tsai (CGU: Chang Gung University)H-Index: 25
view all 7 authors...
Abstract Background Vault RNA 2-1 (VTRNA2-1, also called nc886) is a 108-nucleotide noncoding transcript that is epigenetically controlled via 18 CpG dinucleotide modifications of its promoter, and can exert either tumor suppressor or oncogenic functions depending on cell types of cancers. In hepatocellular carcinoma (HCC), the role of VTRNA2-1 in prognosis of patients remains unexplored. Here, we analysed the methylation status of the VTRNA2-1 promoter and its correlation with clinical paramete...
4 CitationsSource